HDFC Pharma and Healthcare Fund vs ITI Pharma and Healthcare Fund Regular compare
ITI Pharma and Healthcare Fund Regular - Growth
HDFC Pharma and Healthcare Fund - Regular (G)
Chart Comparison
Overview
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| Fund | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹224 Cr | ₹1984 Cr |
| Min Investment | ₹5000 | ₹100 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹1000 | ₹100 |
| Launch Date | 08 Nov 2021 | 04 Oct 2023 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | BSE Healthcare Index |
| Turn Over | % | % |
| Expense Ratio | 2.35 | 2.14 |
| Manager | Rohan Korde | Dhruv Muchhal |
| ISIN Code | INF00XX01BL5 | INF179KC1HL7 |
| Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| 1 Month | -7.05% | -4.6% |
| 6 Month | -12.31% | -6.9% |
| 1 Year | -6.96% | 6.46% |
| 3 Year | 16.29% | - |
| 5 Year | - | - |
SIP Return Analysis
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| 6 Month | -9.06% | -5.31% |
| 1 Year | -16.17% | -3.81% |
| 3 Year | 7% | - |
| 5 Year | - | - |
Rolling Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| 1 Year | 17.33% | 26.12% |
| 3 Year | 19.38% | - |
| 5 Year | - | - |
Risk Management
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| Standard Deviation | 14.52% | - |
| Sharp | 0.82% | - |
| Beta | 0.9% | - |
| Alpha | -1.59% | - |
Fund Managers
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| Name | Rohan Korde | Dhruv Muchhal |
| Total AUM | ₹4626 Cr | ₹520687 Cr |
| Funds Managed | 10 | 40 |
| ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
Market Cap
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| Others | 5.53 | 12.13 |
| Large Cap | 30.13 | 25.91 |
| Mid Cap | 37.01 | 31.4 |
| Small Cap | 27.33 | 30.56 |
Sector Allocation
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
HDFC Pharma and Healthcare Fund - Regular (G) |
|---|---|---|
| Others | 2.11 | 2.21 |
| Healthcare | 93.05 | 94.88 |
| Industrials | 1.04 | - |
| Financial Services | 1.35 | - |
| Basic Materials | 2.46 | 2.91 |
Top Comparisons
Invesco India Liquid Fund - Bonus Option
3Y Returns%
Edelweiss Liquid Fund - Regular Plan - Growth Option
3Y Returns6.88%
SBI Overnight Fund - Regular Plan - Growth
3Y Returns6.27%
DSP Overnight Fund - Regular Plan - Growth
3Y Returns6.31%
Kotak Gold Fund Growth
3Y Returns38.46%
Aditya Birla Sun Life Gold Fund-Growth
3Y Returns38.68%
Tata Gilt Securities Fund -Regular Plan- Growth Option
3Y Returns6.41%
Canara Robeco Gilt Fund - Regular Plan - Growth Option
3Y Returns5.94%